Be cautious of products using terms like "GLP-1 patch" without clarifying that they do not contain pharmaceutical GLP-1 receptor agonists
Before semaglutide, most weight loss drugs were prescribed for short-term use
Here, we show that cancer cells can indeed escape the effects of Doxycycline, by reverting to a purely glycolytic phenotype
Heres what happened: Starting point: Weight: 89.5kg Body fat: 15% Fat mass: 13.4kg Muscle mass: 73.5kg Visceral fat: Level 5 (relatively low) After 3 months: Weight: 77kg Body fat: 8.3% Fat mass: 6.8kg Muscle mass: 71.1kg Visceral fat: Level 2 Total changes: Weight lost: 12.5kg Fat lost: 6.6kg (over a stone of pure fat) Muscle lost: 2.4kg (mostly water, not actual muscle tissue) Visceral fat reduction: 60% Cardiovascular fitness: VO2 max improved from 51 54 (significant increase) Strength: Lost 10-15% on main lifts (bench press, squats, pull-ups)
The clinical implication of that -arrestin-sparing profile is still under investigation, but NIH-funded research published in Nature in May 2026 found that small-molecule GLP-1 drugs access reward circuits deep within the brain circuits involved in hedonic, pleasure-driven feeding through pathways that the larger peptide molecules do not reach, suggesting the two drug classes may suppress appetite through partially distinct neural mechanisms
Renal cell carcinomas
